Literature DB >> 10789356

Cognitive therapy or imaginal exposure in the treatment of post-traumatic stress disorder. Twelve-month follow-up.

N Tarrier1, C Sommerfield, H Pilgrim, L Humphreys.   

Abstract

BACKGROUND: Previously reported results have demonstrated the efficacy of exposure and cognitive therapy in the treatment of chronic post-traumatic stress disorder (PTSD), but have not shown one to be superior to the other. AIMS: To investigate whether treatment benefits and equivalence are maintained at 12-month follow-up in patients with chronic PTSD treated with either imaginal exposure or cognitive therapy.
METHOD: Twelve-month follow-up of a randomised clinical trial.
RESULTS: Fifty-four subjects (87% of the sample) were available to follow-up. They did not significantly differ clinically from drop-outs. There was significant clinical improvement at 12 months compared with pre-treatment. However, 39% of those followed-up still met criteria for PTSD. There were no significant differences between the two treatments. Victims of crime displayed higher levels of symptoms at follow-up than victims of accidents.
CONCLUSIONS: Clinical benefits for exposure or cognitive therapy were maintained.

Entities:  

Mesh:

Year:  1999        PMID: 10789356     DOI: 10.1192/bjp.175.6.571

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  13 in total

1.  Prefrontal cortex long-term potentiation, but not long-term depression, is associated with the maintenance of extinction of learned fear in mice.

Authors:  Cyril Herry; Rene Garcia
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

2.  Challenges and Successes in Dissemination of Evidence-Based Treatments for Posttraumatic Stress: Lessons Learned From Prolonged Exposure Therapy for PTSD.

Authors:  Edna B Foa; Seth J Gillihan; Richard A Bryant
Journal:  Psychol Sci Public Interest       Date:  2013-05

3.  Mental health consequences of long term conflict.

Authors:  Graeme McDonald
Journal:  BMJ       Date:  2007-06-02

4.  Post-extinction fluoxetine treatment prevents stress-induced reemergence of extinguished fear.

Authors:  Olivier Deschaux; Xigeng Zheng; Jennifer Lavigne; Ophélie Nachon; Carine Cleren; Jean-Luc Moreau; René Garcia
Journal:  Psychopharmacology (Berl)       Date:  2012-07-24       Impact factor: 4.530

5.  Exposure therapy for posttraumatic stress disorder in a residential substance use treatment facility.

Authors:  Amber M Henslee; Scott F Coffey
Journal:  Prof Psychol Res Pr       Date:  2010-02-01

6.  Suicide risk in civilian PTSD patients--predictors of suicidal ideation, planning and attempts.

Authors:  Nicholas Tarrier; Lynsey Gregg
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2004-08       Impact factor: 4.328

7.  Insomnia and emotion dysregulation: independent and interactive associations with posttraumatic stress symptoms among trauma-exposed smokers.

Authors:  Nicole A Short; Amanda M Raines; Mary E Oglesby; Michael J Zvolensky; Norman B Schmidt
Journal:  J Affect Disord       Date:  2014-05-04       Impact factor: 4.839

Review 8.  Posttraumatic Stress Disorder: Perspectives for the Use of Deep Brain Stimulation.

Authors:  Roman Reznikov; Clement Hamani
Journal:  Neuromodulation       Date:  2016-12-19

Review 9.  Cognitive-behavioral therapy versus other PTSD psychotherapies as treatment for women victims of war-related violence: a systematic review.

Authors:  N Inès Dossa; Marie Hatem
Journal:  ScientificWorldJournal       Date:  2012-04-19

Review 10.  Is there a neuroscience-based, mechanistic rationale for transcranial direct current stimulation as an adjunct treatment for posttraumatic stress disorder?

Authors:  C R Faucher; R A Doherty; N S Philip; A S M Harle; J J E Cole; M Van't Wout-Frank
Journal:  Behav Neurosci       Date:  2021-08-02       Impact factor: 1.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.